Last10K.com

Actinium Pharmaceuticals, Inc. (ATNM) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

ATNM Quarterly Reports

Actinium Pharmaceuticals, Inc.

CIK: 1388320 Ticker: ATNM
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 13, 2022
Document Information Line Items  
Entity Registrant NameACTINIUMPHARMACEUTICALS, INC. 
Trading SymbolATNM 
Document Type10-Q 
Current Fiscal Year End Date--12-31 
Entity Common Stock, Shares Outstanding 23,784,506
Amendment Flagfalse 
Entity Central Index Key0001388320 
Entity Current Reporting StatusYes 
Entity Filer CategoryNon-accelerated Filer 
Document Period End DateMar. 31, 2022 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ1 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number001-36374 
Entity Incorporation, State or Country CodeDE 
Entity Tax Identification Number74-2963609 
Entity Address, Address Line One275 Madison Ave, 7th Floor 
Entity Address, City or TownNew York 
Entity Address, State or ProvinceNY 
Entity Address, Postal Zip Code10016 
City Area Code(646) 
Local Phone Number677-3870 
Title of 12(b) SecurityCommon stock, par value $0.001 
Security Exchange NameNYSEAMER 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actinium Pharmaceuticals, Inc..

Continue

Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Revenue
Financial
Other
Filter Subcategory:
All
Product
Cash Flow
Geography
Expense
Other
Inside Actinium Pharmaceuticals, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Material Contracts, Statements, Certifications & more

Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ATNM
CIK: 1388320
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-22-026538
Submitted to the SEC: Fri May 13 2022 5:01:29 PM EST
Accepted by the SEC: Fri May 13 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/atnm/0001213900-22-026538.htm